Sigilon Therapeutics Inc 's

• SGTX's Stock Performance relative to its Competitors

Contextlogic Inc Share Performance +41.22% This Quarter

Contextlogic Inc Profile LogicBio Therapeutics Inc is a biotechnology company that focuses on developing and commercializing gene editing technology to treat rare genetic diseases. More about Contextlogic Inc 's Market Share

Pepgen Inc Share Performance -1.24% Over The Past 5 Days

Pepgen Inc Profile Pepgen Inc is a biotechnology company that operates on a business model focused on developing and commercializing transformative therapies for genetic diseases. They leverage their expertise in synthetic biology and gene editing technologies to create novel peptide-based therapies that can address previously untreatable genetic conditions. Pepgen Inc aims to partner with healthcare organizations and pharmaceutical companies to bring their innovative treatments to market. More about Pepgen Inc 's Market Share

Precigen Inc Share Performance -5.53% Over The Past 5 Days

Precigen Inc Profile Precigen Inc is a biotechnology company that focuses on the development and commercialization of innovative genetic therapies. Their business model revolves around leveraging their proprietary technologies and expertise in gene editing and synthetic biology to create transformative medical solutions. With a strong emphasis on research and development, Precigen aims to bring cutting-edge genetic therapies to market and address critical unmet medical needs. More about Precigen Inc 's Market Share

Point Biopharma Global Inc Share Performance +73.13% This Year

Point Biopharma Global Inc Profile Point Biopharma Global Inc is a pharmaceutical company that specializes in the development and commercialization of innovative radiopharmaceuticals for cancer treatment. Their business model involves leveraging advanced imaging technologies and targeted therapies to provide precise and personalized treatments to patients. By focusing on radiopharmaceuticals, Point Biopharma aims to revolutionize cancer therapy and improve patient outcomes. More about Point Biopharma Global Inc 's Market Share

Praxis Precision Medicines Inc Share Performance +6.67% This Quarter

Praxis Precision Medicines Inc Profile Praxis Precision Medicines Inc's business model revolves around developing precision medicines for the treatment of various central nervous system (CNS) disorders. More about Praxis Precision Medicines Inc 's Market Share

Sources: Sigilon Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 3, 2026 12:01 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Sigilon Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.